Affinage

ZNF638

Zinc finger protein 638 · UniProt Q14966

Length
1978 aa
Mass
220.6 kDa
Annotated
2026-06-11
12 papers in source corpus 10 papers cited in narrative 10 extracted findings
Cross-family judge vs UniProt: Affinage preferred faithfulness: 5/5 claims corpus-supported (100%)

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

ZNF638 (NP220) is a DNA-binding nuclear zinc finger protein that functions as a sequence-targeted epigenetic silencer of foreign and repetitive DNA and as a transcriptional cofactor in adipocyte biology (PMID:30487602, PMID:21602272). As a silencer, ZNF638 binds extrachromosomal viral and repeat DNA and recruits the HUSH complex (MPP8, TASOR, PPHLN1) together with the methyltransferase SETDB1 to deposit repressive H3K9me3, and additionally recruits HDAC1 and HDAC4 for histone deacetylation; this activity restricts unintegrated retroviral DNA, persisting rAAV episomes, HBV cccDNA, and endogenous retroelements, with loss of ZNF638 reducing H3K9me3 and de-repressing these targets (PMID:30487602, PMID:34878926, PMID:41689010, PMID:39464150). In adipose tissue, ZNF638 physically associates with C/EBPβ and C/EBPδ to induce PPARγ and drive adipocyte differentiation, and it acts as an HDAC1-recruiting repressor of lipogenic genes including Angptl8 (PMID:21602272, PMID:38211696). ZNF638 also localizes to nuclear speckles and regulates alternative splicing of metabolic transcripts such as lipin1 and NCoR1, a function requiring its arginine/serine-rich motif and C-terminal zinc finger domain (PMID:25024404). Its transcription is driven by CREB binding to cAMP response elements in its promoter, and its protein stability is controlled by the deubiquitinase USP7, which links it to SREBP1C-dependent lipogenesis (PMID:31745529, PMID:33040080).

Mechanistic history

Synthesis pass · year-by-year structured walk · 9 steps
  1. 1998 Low

    Established the molecular identity of NP220/ZNF638 as a nuclear DNA-binding protein with defined RNA/DNA-interacting motifs, framing it as a candidate nucleic-acid-binding regulator before any function was known.

    Evidence FISH chromosomal mapping and domain analysis of human NP220

    PMID:9757574

    Open questions at the time
    • Chromosomal mapping only, no functional mechanistic assay
    • No binding targets or interaction partners identified
    • No cellular role assigned
  2. 2011 Medium

    Answered what role ZNF638 plays in cell differentiation by showing it is a transcriptional cofactor of C/EBP proteins required to induce PPARγ and drive adipogenesis.

    Evidence Co-IP, ectopic expression and siRNA knockdown with transcriptional readouts in adipocyte differentiation

    PMID:21602272

    Open questions at the time
    • Single lab
    • Direct DNA binding sites for ZNF638 in adipogenic loci not mapped
    • Mechanism linking cofactor activity to PPARγ promoter not resolved at structural level
  3. 2014 Medium

    Extended ZNF638's regulatory repertoire beyond transcription by demonstrating it localizes to splicing-factor-rich nuclear bodies and directs alternative splicing of metabolic transcripts through its RS and zinc finger domains.

    Evidence Biochemical purification/MS, minigene splicing reporters, structure-function mutagenesis, immunofluorescence

    PMID:25024404

    Open questions at the time
    • Specific splicing regulator partners not individually validated
    • Mechanism coupling C/EBP recruitment to splicing not detailed
    • Single lab
  4. 2018 High

    Defined the core silencing mechanism by showing NP220 directly binds unintegrated retroviral DNA and recruits the HUSH complex, SETDB1, and HDAC1/4 to epigenetically silence it.

    Evidence Genome-wide CRISPR screen, ChIP, knockout validation across viral contexts

    PMID:30487602

    Open questions at the time
    • DNA sequence determinants of ZNF638 targeting not defined
    • Order of HUSH/SETDB1/HDAC recruitment not resolved
    • Structural basis of DNA recognition unknown
  5. 2019 Medium

    Resolved how ZNF638 expression is controlled, identifying direct CREB binding to promoter cAMP response elements and selective induction in thermogenic adipocytes by cold and β-adrenergic signaling.

    Evidence EMSA, ChIP, in vivo cold and β-adrenergic stimulation, expression analysis

    PMID:31745529

    Open questions at the time
    • Functional consequence of thermogenic-specific expression not fully resolved
    • Single lab
    • Link between CREB-driven expression and silencing activity not established
  6. 2020 Medium

    Identified post-translational control of ZNF638 by USP7-mediated deubiquitination and connected the axis to SREBP1C-driven hepatic lipogenesis and steatosis.

    Evidence Co-IP, ubiquitination assay, fructose-induced steatosis mouse model, signaling analysis

    PMID:33040080

    Open questions at the time
    • E3 ligase opposing USP7 not identified
    • Direct vs indirect role in SREBP1C cleavage not separated
    • Single lab
  7. 2024 Medium

    Demonstrated an HDAC1-dependent repressive function of ZNF638 over lipid metabolic genes in vivo, with Angptl8 as a key target and an estrogen-dependent sexually dimorphic phenotype.

    Evidence Adipose-specific knockout mice, adenoviral overexpression, RNA-seq, ANGPTL8 neutralization

    PMID:38211696

    Open questions at the time
    • Mechanism of estrogen-dependent regulation not resolved
    • Direct ChIP at Angptl8 promoter only implied
    • Single lab
  8. 2024 Medium

    Generalized the silencing role to endogenous retroelements and linked loss of ZNF638 to dsRNA-sensing innate immune activation and PD-L1 upregulation in glioblastoma.

    Evidence siRNA knockdown, H3K9me3 ChIP, dsRNA detection, immune signaling analysis, orthotopic GBM models (preprint)

    PMID:39464150

    Open questions at the time
    • Preprint not yet peer-reviewed
    • Specific retroelement targets not fully cataloged
    • Therapeutic relevance of immune activation not established
  9. 2026 Medium

    Showed ZNF638 directly binds HBV cccDNA at the preS/S region and represses its transcription via HUSH/SETDB1-mediated H3K9me3, with knockdown impairing HBV RNAi therapy in vivo.

    Evidence ChIP, nuclear cccDNA pulldown, FISH-IF, qRT-PCR, ELISA, HBV transgenic mouse model with siRNA

    PMID:41689010

    Open questions at the time
    • Sequence specificity of cccDNA recognition not mapped
    • Interplay between silencing and therapy response mechanistically incomplete
    • Single lab

Open questions

Synthesis pass · forward-looking unresolved questions
  • The DNA sequence determinants and structural basis by which ZNF638 selects its diverse targets (retroviral DNA, episomes, cccDNA, retroelements, host promoters) remain undefined, as does how silencing and splicing/transcriptional-cofactor functions are partitioned.
  • No structure of ZNF638 bound to DNA
  • Consensus recognition motif not established
  • Mechanism switching between silencer, cofactor, and splicing roles unknown

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Molecular activity
GO:0003677 DNA binding 3 GO:0140110 transcription regulator activity 3 GO:0060090 molecular adaptor activity 2
Localization
GO:0005634 nucleus 2 GO:0005654 nucleoplasm 1
Pathway
R-HSA-4839726 Chromatin organization 4 R-HSA-1643685 Disease 3 R-HSA-74160 Gene expression (Transcription) 3
Partners
CEBPBCEBPDHDAC1MPP8PPHLN1SETDB1TASORUSP7
Complex memberships
HUSH complex

Evidence

Reading pass · 10 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
2018 NP220 (ZNF638) is a DNA-binding protein that recruits the HUSH complex (MPP8, TASOR, PPHLN1), the histone methyltransferase SETDB1, and histone deacetylases HDAC1 and HDAC4 to unintegrated retroviral DNA, thereby mediating its epigenetic silencing. Knockout of NP220 accelerates retroviral replication. Genome-wide CRISPR-Cas9 screen, chromatin immunoprecipitation (ChIP), knockout validation Nature High 30487602
2011 ZNF638 physically interacts with C/EBPβ and C/EBPδ and transcriptionally cooperates with them to induce PPARγ expression, thereby acting as a transcriptional cofactor required for adipocyte differentiation. Ectopic expression increases adipogenesis; knockdown inhibits differentiation. Co-immunoprecipitation, ectopic expression, siRNA knockdown, gene expression assays The Journal of biological chemistry Medium 21602272
2014 ZNF638 localizes to nuclear bodies enriched with splicing factors and interacts with splicing regulators (identified by biochemical purification and mass spectrometry). ZNF638 is sufficient to promote alternative splicing; its arginine/serine-rich motif and C-terminal zinc finger domain are required for speckle localization, adipocyte differentiation function, and regulation of alternatively spliced isoforms of lipin1 and NCoR1. Recruitment to promoters via C/EBP proteins enhances alternative splicing activity. Biochemical purification, mass spectrometry, minigene reporter splicing assay, structure-function mutagenesis, immunofluorescence localization Journal of lipid research Medium 25024404
2019 CREB binds directly to two cAMP response elements within 500 bp of the ZNF638 transcription start site and is necessary and sufficient to drive ZNF638 transcription. ZNF638 is selectively expressed in mature thermogenic (brown and beige) adipocytes in vivo and is induced by cAMP modulators, cold exposure, and β-adrenergic stimulation. EMSA, chromatin immunoprecipitation (ChIP), in vivo cold-exposure and β-adrenergic stimulation, gene expression analysis Journal of the Endocrine Society Medium 31745529
2020 USP7 (a deubiquitinase) interacts with ZNF638, deubiquitylates it (stabilizing the protein), and also promotes ZNF638 transcription via CREB stabilization. The USP7/ZNF638 axis selectively increases SREBP1C cleavage through AKT/mTORC1/S6K signaling and forms a nuclear complex with SREBP1C to transcriptionally regulate lipogenic enzymes (ACACA, FASN, SCD). Abrogation of USP7 or ZNF638 ameliorates liver steatosis in mice. Co-immunoprecipitation, ubiquitination assay, in vivo mouse model (fructose-induced steatosis), knockdown/knockout, signaling pathway analysis Cell death & disease Medium 33040080
2021 NP220 (ZNF638), in association with the HUSH complex, mediates transcriptional silencing of recombinant AAV (rAAV) genomes (both single-stranded and self-complementary) persisting as extrachromosomal episomes. Loss of NP220 or HUSH complex components increases AAV transcript levels and reduces repressive H3K9me3 marks on associated histones. The AAV capsid serotype influences the extent of NP220-mediated silencing. CRISPR knockout, qRT-PCR (transcript levels), H3K9me3 chromatin analysis, comparison across AAV serotypes Journal of virology Medium 34878926
2024 ZNF638 functions as a transcriptional repressor in adipose tissue by recruiting HDAC1 for histone deacetylation, thereby suppressing broad lipid metabolic genes including Angptl8. In adipose-specific ZNF638 knockout female mice, Angptl8 is upregulated, leading to reduced LPL activity and elevated serum TG after refeeding. The sexual dimorphism is due to estrogen-dependent regulation of the ZNF638-ANGPTL8 axis. Adipose-specific knockout mice (ZNF638 flox × Adiponectin-Cre), adenoviral overexpression, RNA-sequencing, ANGPTL8 neutralization, ChIP-implied HDAC1 recruitment assay Metabolism: clinical and experimental Medium 38211696
2024 ZNF638 recruits the HUSH complex to deposit repressive H3K9me3 marks on endogenous retroelements in glioblastoma cells. ZNF638 knockdown decreases H3K9 trimethylation, increases cytosolic dsRNA, activates intracellular dsRNA-sensing cascades (RIG-I, MDA5, IRF3), and upregulates antiviral immune programs including PD-L1 expression. siRNA knockdown, H3K9me3 ChIP, dsRNA detection, immune signaling pathway analysis, syngeneic murine orthotopic GBM models bioRxivpreprint Medium 39464150
2026 ZNF638 binds the preS and S gene regions of HBV cccDNA (demonstrated by ChIP and nuclear HBV cccDNA pulldown assays) and represses cccDNA transcription by recruiting the HUSH complex and increasing H3K9me3 modification via SETDB1. In vivo, ZNF638 siRNA knockdown significantly compromised HBV RNAi therapy efficacy in HBV transgenic mice. Chromatin immunoprecipitation, nuclear HBV cccDNA pulldown, FISH-IF, qRT-PCR, ELISA, in vivo HBV transgenic mouse model with siRNA knockdown Cell communication and signaling : CCS Medium 41689010
1998 Human NP220 (ZNF638) is a DNA-binding nuclear protein with an arginine/serine-rich motif and a polypyrimidine tract-binding motif, mapped by FISH to chromosome band 2p13.1-p13.2. NP220 and matrin 3 are considered to form a novel family of nuclear proteins. Fluorescence in situ hybridization (FISH), domain analysis Bioscience, biotechnology, and biochemistry Low 9757574

Source papers

Stage 0 corpus · 12 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
2018 NP220 mediates silencing of unintegrated retroviral DNA. Nature 102 30487602
2011 Regulation of adipocyte differentiation by the zinc finger protein ZNF638. The Journal of biological chemistry 63 21602272
2021 Epigenetic Silencing of Recombinant Adeno-associated Virus Genomes by NP220 and the HUSH Complex. Journal of virology 52 34878926
2020 USP7 mediates pathological hepatic de novo lipogenesis through promoting stabilization and transcription of ZNF638. Cell death & disease 43 33040080
2014 The adipogenic transcriptional cofactor ZNF638 interacts with splicing regulators and influences alternative splicing. Journal of lipid research 28 25024404
1998 Mapping of human DNA-binding nuclear protein (NP220) to chromosome band 2p13.1-p13.2 and its relation to matrin 3. Bioscience, biotechnology, and biochemistry 16 9757574
2025 Multiple sclerosis severity variant in DYSF-ZNF638 locus associates with neuronal loss and inflammation. iScience 11 40352730
2019 Transcriptional Regulation of ZNF638 in Thermogenic Cells by the cAMP Response Element Binding Protein in Male Mice. Journal of the Endocrine Society 10 31745529
2022 N6-Methyladenosine modification (m6A) of circRNA-ZNF638 contributes to the induced activation of SHF stem cells through miR-361-5p/Wnt5a axis in cashmere goats. Animal bioscience 8 36397699
2024 Zinc finger protein ZNF638 regulates triglyceride metabolism via ANGPTL8 in an estrogen dependent manner. Metabolism: clinical and experimental 5 38211696
2024 Targeting ZNF638 activates antiviral immune responses and potentiates immune checkpoint inhibition in glioblastoma. bioRxiv : the preprint server for biology 2 39464150
2026 ZNF638 represses the transcription of HBV closed circular DNA involving HUSH complex-mediated histone modifications of epigenetic silencing. Cell communication and signaling : CCS 0 41689010

Missed literature

Know a paper Affinage missed for ZNF638? Flag it for the maintainers and the community.

No submissions yet.